BNBX
Applied DNA Sciences, Inc.
NASDAQ: BNBX · FINANCIAL SERVICES · ASSET MANAGEMENT
$0.53
+3.91% today
Updated 2026-04-30
Market cap
$2.93M
P/E ratio
0.00
P/S ratio
1.60x
EPS (TTM)
$282.39
Dividend yield
—
52W range
$0 – $14
Volume
1.0M
Applied DNA Sciences, Inc. (BNBX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $9.03M | $18.17M | $13.37M | $3.43M | $2.14M |
| Revenue growth (YoY) | — | +101.3% | -26.4% | -74.3% | -37.7% |
| Cost of revenue | $4.54M | $13.12M | $7.83M | $2.41M | $1.30M |
| Gross profit | $4.48M | $5.05M | $5.53M | $1.02M | $838907.00 |
| Gross margin | 49.7% | 27.8% | 41.4% | 29.6% | 39.3% |
| R&D | $4.16M | $3.93M | $3.74M | $3.59M | $6.02M |
| SG&A | $12.85M | $15.10M | $12.75M | $11.45M | $10.87M |
| Operating income | $-13.35M | $-13.97M | $-10.95M | $-14.02M | $-16.05M |
| Operating margin | -147.9% | -76.9% | -81.9% | -408.7% | -750.9% |
| EBITDA | $-11.68M | $-12.68M | $-9.59M | $-13.33M | $-15.66M |
| EBITDA margin | -129.4% | -69.8% | -71.7% | -388.4% | -732.9% |
| EBIT | $-12.53M | $-13.97M | $-10.95M | $-14.02M | $-16.05M |
| Interest expense | — | — | — | — | — |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-14.29M | $-8.27M | $-9.95M | $-6.99M | $-15.16M |
| Net income growth (YoY) | — | +42.1% | -20.3% | +29.7% | -116.8% |
| Profit margin | -158.3% | -45.5% | -74.4% | -203.8% | -709.5% |